These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 16964384

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention.
    Wang L, Liu D, Ahmed T, Chung FL, Conaway C, Chiao JW.
    Int J Oncol; 2004 Jan; 24(1):187-92. PubMed ID: 14654956
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane.
    Fimognari C, Nüsse M, Cesari R, Iori R, Cantelli-Forti G, Hrelia P.
    Carcinogenesis; 2002 Apr; 23(4):581-6. PubMed ID: 11960909
    [Abstract] [Full Text] [Related]

  • 6. p38 MAPK plays a distinct role in sulforaphane-induced up-regulation of ARE-dependent enzymes and down-regulation of COX-2 in human bladder cancer cells.
    Shan Y, Wang X, Wang W, He C, Bao Y.
    Oncol Rep; 2010 Apr; 23(4):1133-8. PubMed ID: 20204301
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sulforaphane down-regulates COX-2 expression by activating p38 and inhibiting NF-kappaB-DNA-binding activity in human bladder T24 cells.
    Shan Y, Wu K, Wang W, Wang S, Lin N, Zhao R, Cassidy A, Bao Y.
    Int J Oncol; 2009 Apr; 34(4):1129-34. PubMed ID: 19287971
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multi-targeted prevention of cancer by sulforaphane.
    Clarke JD, Dashwood RH, Ho E.
    Cancer Lett; 2008 Oct 08; 269(2):291-304. PubMed ID: 18504070
    [Abstract] [Full Text] [Related]

  • 17. Protective Effect of Isothiocyanates from Cruciferous Vegetables on Breast Cancer: Epidemiological and Preclinical Perspectives.
    Ngo SNT, Williams DB.
    Anticancer Agents Med Chem; 2021 Oct 08; 21(11):1413-1430. PubMed ID: 32972351
    [Abstract] [Full Text] [Related]

  • 18. Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells.
    Yao H, Wang H, Zhang Z, Jiang BH, Luo J, Shi X.
    Int J Cancer; 2008 Sep 15; 123(6):1255-61. PubMed ID: 18561315
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells.
    Tang L, Li G, Song L, Zhang Y.
    Anticancer Drugs; 2006 Mar 15; 17(3):297-305. PubMed ID: 16520658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.